Avivagen announced that Cameron Groome has stepped down as President, Chief Executive Officer and Director, effective immediately. The Board of Directors has commenced a search to recruit a successor in which it will be assisted by an executive search firm. During this process, Mr. Kym Anthony, Chairman of the Board of Directors, will serve as Interim CEO while continuing as Chairman.

Mr. Anthony is a company builder and has experience in the agriculture and agricultural technology markets. More recently, Kym was the Chair of the Board of Directors of Prometic Life Sciences from 2011 to 2014 and a Director of Com Dev International, which sold last year to Honeywell for $455 million.